LY2857785 TQ0060
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LY2857785 is a type I competitive and reversible ATP kinase inhibitor against CDK7/CDK8/CDK9 (IC50s: 246 nM/16 nM/11 nM).
CAS nr:
1619903-54-6
Purity:
98%
Molecular Weight:
448,6
SMILES:
CC(C)c1c(cc(cc2)-c3ccnc(N[C@H](CC4)CC[C@@H]4NC4CCOCC4)n3)c2nn1C
Formula:
C26H36N6O
Pathway:
Apoptosis,Cell Cycle/Checkpoint
Target:
Apoptosis,CDK
